Skip to content

In the BioHarmony Drug Report Database

Gemifloxacin

Factive (gemifloxacin) is a small molecule pharmaceutical. Gemifloxacin was first approved as Factive on 2003-04-04. It is used to treat bacterial infections, bronchitis, community-acquired infections, gram-negative bacterial infections, and pneumococcal pneumonia amongst others in the USA.
Trade Name Factive
Common Name Gemifloxacin
Indication bacterial infections, bronchitis, community-acquired infections, gram-negative bacterial infections, pneumococcal pneumonia, protozoan infections, urinary tract infections
Drug Class Antibacterials (quinolone derivatives)
Gemifloxacin
Get full access now